Implementing primary prevention for peanut allergy at a population level

JAMA - Journal of the American Medical Association

Volumn 317, Issue 11, 2017, Pages 1111-1112

  Turner, Paul J ^a,b   Campbell, Dianne E ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

DISEASE PREDISPOSITION; DISEASE SEVERITY; ECZEMA; FATALITY; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; NOTE; PEANUT ALLERGY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK FACTOR; TREATMENT PLANNING; AGE; ANAPHYLAXIS; COMPLICATION; FOOD HYPERSENSITIVITY; HEALTH SERVICE; INFANT; INTENTION TO TREAT ANALYSIS; MORTALITY; NATIONAL HEALTH ORGANIZATION; PEANUT HYPERSENSITIVITY; PRE-EXPOSURE PROPHYLAXIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES;

AGE FACTORS; ANAPHYLAXIS; ECZEMA; FOOD HYPERSENSITIVITY; HUMANS; INFANT; INTENTION TO TREAT ANALYSIS; MEDICAL OVERUSE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (U.S.); PEANUT HYPERSENSITIVITY; PRACTICE GUIDELINES AS TOPIC; PRE-EXPOSURE PROPHYLAXIS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 85016110949     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.0922     Document Type: Note

References (10)

1. Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics. 2011;128(1):e9-e17.
2. Perkin MR, Logan K, Tseng A, et al; EAT Study Team. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. N Engl J Med. 2016;374(18):1733-1743.
3. Osborne NJ, Koplin JJ, Martin PE, et al; HealthNuts Investigators. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol. 2011;127(3):668-76.e1, 2.
4. Du Toit G, Roberts G, Sayre PH, et al; LEAP Study Team. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015; 372(9):803-813.
5. Du Toit G, Sayre PH, Roberts G, et al; Immune Tolerance Network LEAP-On Study Team. Effect of avoidance on peanut allergy after early peanut consumption. N Engl J Med. 2016;374(15):1435-1443.
6. Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017;139(1):29-44.
7. Greenhawt M, Fleischer D, Chan ES, et al. LEAPing through the looking glass: Secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introduction. Allergy. 2016;13100.
8. Turner PJ, Campbell DE. Epidemiology of severe anaphylaxis: Can we use population-based data to understand anaphylaxis?. Curr Opin Allergy Clin Immunol. 2016;16(5):441-450.
9. Koplin JJ, Peters RL, Dharmage SC, et al; HealthNuts study investigators. Understanding the feasibility and implications of implementing early peanut introduction for prevention of peanut allergy. J Allergy Clin Immunol. 2016;138(4):1131-1141.e2.
10. O'Connor C, Kelleher M, O'B Hourihane J. Calculating the effect of population-level implementation of the Learning Early About Peanut Allergy (LEAP) protocol to prevent peanut allergy. J Allergy Clin Immunol. 2016;137(4):1263-4.e1, 2.